Photosensitizing potencies of the structural analogues of benzoporphyrin derivative in different biological test systems

Journal of Clinical Laser Medicine and Surgery

Volumn 14, Issue 5, 1996, Pages 335-341

  Richter, A M ^a,b   Yip, S ^a   Meadows, H ^a   Jain, A K ^a   Neyndorff, H ^b   Moreno, G ^c   Salet, C ^c   Levy, J G ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b QLT PhotoTherapeutics Inc   (Canada)

^c MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; COMPOSITION EFFECTS; DERIVATIVES; DRUG PRODUCTS; ONCOLOGY; PHOTOCHEMICAL REACTIONS; PHOTOSENSITIVITY;

BENZOPORPHYRIN DERIVATIVES; PHOTOSENSITIZERS; PHOTOSENSITIZING POTENCIES; TUMOR CELL LINES;

PHOTODYNAMIC THERAPY;

BENZOPORPHYRIN DERIVATIVE; PHOTOFRIN; PHOTOSENSITIZING AGENT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DIFFUSION; DRUG POTENCY; DRUG STRUCTURE; DRUG TARGETING; HEMOLYSIS; HUMAN; HUMAN CELL; LIPOPHILICITY; LIVER MITOCHONDRION; MOUSE; NONHUMAN; PARTITION COEFFICIENT; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE; VIRUS INACTIVATION;

EID: 0030273151     PISSN: 10445471     EISSN: None     Source Type: Journal    
DOI: 10.1089/clm.1996.14.335     Document Type: Article

References (32)

1. Berg, K., and Moan, J. (1992). Photochemotherapy of cancer: Experimental research. Photochem. Photobiol. 54, 931-948.
2. Agarwal, M.L., Clay, M.E., Harvey, E.J., Evans, H.H., Antunez, A.R., and Oleinick, N.L. (1991). Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res. 51, 5993-5996.
3. Zaidi, S.I.A., Oleinick, N.L., Zaim, M.T., and Mukhtar, H. (1993). Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumours in C3H mice: Electron microscopic, histopathologic and biochemical evidence. Photochem. Photobiol. 58, 771-776.
4. Dougherty, T.J. (1993). Photodynamic therapy. Photochem. Photobiol. 58, 895-900.
5. Levy, J.G., Chan, A., and Strong, A. (1996). The clinical status of benzoporphyrin derivative. Proc. SPIE 2625, 86-95.
6. North, J., Coombs, R., and Levy, J. (1992). Photoinactivation of HIV benzoporphyrin derivative, in: Photodynamic Therapy and Biomedical Lasers. P. Spinelli, M. Dal Fante, and R. Marchesini (eds.). Amsterdam: Elsevier Science Publishers B.V., pp. 103-110.
7. Jamieson, C., Richter, A., and Levy, J.G. (1993). Efficacy of benzoporphyrin derivative, a photosensitizer, in selective destruction of leukemia cells using a murine tumor model. Exp. Hematol. 21, 629-634.
8. Hsiang, Y.N., Crespo, M.T., Richter, A.M., Jain, A.K., Fragoso, M., and Levy, J.G. (1993). In vitro and in vivo uptake of benzoporphyrin derivative into human and miniswine atherosclerotic plaque. Photochem. Photobiol. 57, 670-674.
9. Richter, A.M., Chowdhary, R., Ratkay, L., Jain, A.K., Canaan, A.J., Meadows, H., Obochi, M., Waterfield, D., and Levy, J. (1994). Non-oncologic potentials for photodynamic therapy. Proc. SPIE 2078, 293-304.
10. Levy, J.G., Chowdhary, R., Ratkay, L., Waterfield, D., Obochi, M., Leong, S., Hunt, D., and Chan, A. (1995). Immune modulation using transdermal photodynamic therapy. Proc. SPIE 2325, 155-165.
11. Chowdhary, R., Ratkay, L.G., Neyndorff, H.C., Richter, A., Obochi, M., Waterfield, J.D., and Levy, J.G. (1994). The use of transcutaneous photodynamic therapy in the prevention of adjuvant-enhanced arthritis in MRL/lpr mice. Clin. Immunol. Immunopath. 72, 255-263.
12. Hunt, D.W.C., Leong, S., Levy, J.G., and Chan, A.H. (1995). Transcutaneous photodynamic therapy delays the onset of paralysis in a murine multiple sclerosis model. Proc. SPIE 2371, 451-455.
13. Obochi, M.O.K., Canaan, A.J., Jain, A.K., Richter, A.M., and Levy, J.G. (1995). Targeting activated lymphocytes with photodynamic therapy: Susceptibility of mitogen-stimulated splenic lymphocytes to benzoporphyrin derivative (BPD) photosensitization. Photochem. Photobiol. 62, 169-175.
14. Richter, A.M., Waterfield, E., Jain, A.K., Allison, B., Sternberg, E.D., Dolphin, D., and Levy, J.G. (1991). Photosensitizing potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model. Br. J. Cancer 63, 87-93.
15. Moan, J., Peng, Q., Evensen, J.F., Berg, K., Western, A., and Rimington, C. (1987). Photosensitizing efficiencies, tumor and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem. Photobiol. 46, 713-721.
16. Bordier, C. (1981). Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 256, 1604-1607.
17. Neyndorff, H.C., Bartel, D.L., Tufaro, F., and Levy, J.G. (1990). Development of a model to demonstrate photosensitizer-mediated viral inactivation in blood. Transfusion 30, 485-490.
18. Salet, C., Moreno, G., and Vinzens, F. (1982). Photodynamic effects induced by furocoumarins on a membrane system: Comparison with hematoporphyrin. Photochem. Photobiol. 36, 291-296.
19. Waddell, W.J. (1956). A simple ultraviolet spectrophotometric method for the determination of protein. J. Lab. Clin. Med. 48, 311-314.
20. Richter, A.M., Waterfield, E., Jain, A.K., Sternberg, E.D., Dolphin, D., and Levy, J.G. (1990). In vitro evaluation of phototoxic properties of four structurally related benzoporphyrin derivatives. Photochem. Photobiol. 52, 495-500.
21. 3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice. J. Photochem. Photobiol. B. 5, 231-244.
22. Aveline, B., Hasan, T., and Redmond, R.W. (1994). Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA). Photochem. Photobiol. 59, 328-335.
23. Emiliani, C., and Delmelle, M. (1983). The lipid solubility of porphyrins modulates their phototoxicity in membrane models. Photochem. Photobiol. 37, 487-490.
24. Richter, A.M., Meadows, H., Jain, A.K., Canaan, A.J., and Levy J. (1995). Kinetics of cellular uptake and retention of the benzoporphyrin derivative (BPD); relevance to photodynamic therapy. Proc. SPIE 2325, 189-197.
25. Masutani, M., Richter, A.M., Dolphin, D., Levy, J.G., and Horie, T. (1995). In vitro evaluation of benzoporphyrin derivatives using cultured cancer cells for photodynamic therapy. Nihon Univ. J. Med. 37, 203-214.
26. Margaron, P., Gregoire, M.-J., Scasnar, V., Ali, H., and van Lier, J.E. (1996). Structure-photodynamic activity relationships of a series of 4-substituted zinc phthalocyanines. Photochem. Photobiol. 63, 217-223.
27. Pooler, J.P., and Valenzeno, D.P. (1979). Physicochemical determinants of the sensitizing effectiveness for photooxidation of nerve membranes by fluorescein derivatives. Photochem. Photobiol. 30, 491-498.
28. Jain, A.K., Richter, A.M., Neyndorff, H.C., and Levy, J.G. (1994). The potential of benzoporphyrin derivative (BPD) as a photosensitizer of blood-borne targets. Oncology (Life Sci. Adv.) 13, 33-42.
29. Pooler, J.P. (1981). Dye-sensitized photodynamic inactivation of cells. Med. Phys. 8, 614-628.
30. Pooler, J.P. (1986). A new hypothesis for the target in photohemolysis: Dimers of the band 3 protein. Photochem. Photobiol. 43, 263-266.
31. Pompei, R., Ingiannai, A., Foddis, G., and Cisani, G. (1989). Differential viral sensitivity to photoinactivation by haematoporphyrin and haematoporphyrin derivative. Microbios Lett. 40, 19-23.
32. 2 uptake in liver mitochondria. Biochem. Biophys. Res. Commun. 115(1), 76-81.